Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2009
09/01/2009US7582761 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582749 capable of switching between the two states in response to at least actinic radiation; thermally reversible
09/01/2009US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
09/01/2009US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring
09/01/2009US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/01/2009US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
09/01/2009US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582641 Gyrase inhibitors and uses thereof
09/01/2009US7582632 Tri(cyclo) substituted amide compounds
09/01/2009US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them
09/01/2009US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
09/01/2009CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them
09/01/2009CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
08/2009
08/27/2009WO2009105774A2 Amino acid inhibitors of cytochrome p450
08/27/2009WO2009105746A2 Triazoles and processes for producing the same
08/27/2009WO2009105722A1 Compounds and compositions as modulators of gpr119 activity
08/27/2009WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor
08/27/2009WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2009104488A1 White light-emitting organic electroluminescent device
08/27/2009WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/27/2009WO2009103966A1 Bicyclylaryl-aryl-amine compounds and their use
08/27/2009WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
08/27/2009WO2009012280A3 Benzimidazole poly(adp-ribose)polymerase inhibitors
08/27/2009WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors
08/27/2009US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/27/2009US20090216024 Processes for making pioglitazone and compounds of the processes
08/27/2009US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
08/27/2009US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
08/27/2009US20090216009 Process for the production of ezetimibe and intermediates used in this process
08/27/2009US20090215993 Mycophenolic acid immunogens and antibodies
08/27/2009US20090215856 Methods for monitoring IL-18
08/27/2009US20090215815 Neurotrophin antagonist compositions
08/27/2009US20090215802 Deuterium-enriched lapatinib
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215776 Organic compounds
08/27/2009US20090215770 Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases
08/27/2009US20090215767 Isoflavone derivatives and pharmaceutical compositions comprising the same
08/27/2009US20090215759 Modulators for amyloid beta
08/27/2009US20090215712 Pyrazole derivatives
08/27/2009US20090215705 Alpha 7 Nicotinic Receptor Selective Ligands
08/27/2009US20090214675 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof
08/27/2009CA2716515A1 Amine and ether compounds which modulate the cb2 receptor
08/27/2009CA2716349A1 Methods for inhibiting drug degradation
08/27/2009CA2716348A1 Diamide inhibitors of cytochrome p450
08/27/2009CA2716347A1 Amino acid inhibitors of cytochrome p450
08/27/2009CA2716332A1 Compounds and compositions as modulators of gpr119 activity
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
08/27/2009CA2714122A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
08/27/2009CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/26/2009EP2091947A2 Glucokinase activators
08/26/2009EP2091945A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091941A2 Mapk/erk kinase inhibitors
08/26/2009EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
08/26/2009EP2091933A1 Dihydrobenzofuranyl derivatives and methods of their use
08/26/2009EP2091924A1 Pyrimidine derivatives and their use as pesticides
08/26/2009EP2091916A2 L-phenylalanine derivatives and their use as integrin antagonists
08/26/2009EP1981878B1 Indazole heteroaryl derivatives
08/26/2009EP1773817B1 Substituted aryl-amine derivatives and methods of use
08/26/2009EP1745033A4 4,5-disubstituted-2-aryl pyrimidines
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009EP1501804B1 Isoquinoline derivatives mao-b inhibitors
08/26/2009EP1173441B1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
08/26/2009CN101516874A Pyrrole derivatives useful for the treatment of cytokine-mediated diseases
08/26/2009CN101516871A Novel pyridazine derivatives
08/26/2009CN101516868A Novel pyridazine derivatives
08/26/2009CN101516852A Quinoline derivatives with 5-HT-binding properties
08/26/2009CN101516366A Oxindole derivatives as anticancer agents
08/26/2009CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
08/26/2009CN101513402A Antiviral agent
08/26/2009CN100532379C Preparation process of quinamine alcohol
08/26/2009CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same
08/26/2009CN100532364C 5-substituted-alkylaminopyrazole derivatives as pesticides
08/25/2009US7579488 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; [(2-{1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethylpropyl}-benzofuran-5-carbonyl)-amino]-acetic acid
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579369 CB 1 receptor inverse agonists
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/25/2009US7579357 Antidiabetic agents; obesity; controlling appetite
08/25/2009US7579352 Retinoic acid mimetic anilides
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009CA2474578C Novel pyridin- and pyrimidin-derivatives
08/25/2009CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa
08/25/2009CA2269246C Substituted tricyclics
08/20/2009WO2009102633A1 Hepatitis c virus inhibitors
08/20/2009WO2009102568A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
08/20/2009WO2009102325A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
08/20/2009WO2009077068A9 Ester derivatives as phosphodiesterase inhibitors
08/20/2009WO2009074749A3 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/20/2009WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/20/2009US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor
08/20/2009US20090209607 Inhibitors of akt activity
08/20/2009US20090209590 Histone Deacetylase and Tubulin Deacetylase Inhibitors
08/20/2009US20090209568 Spiro [Benzopyran] or Spiro [Benzofuran] Derivatives Which Inhibit the Sigma Receptor
08/20/2009US20090209563 Pyridinoylpiperidines as 5-HT1F agonists
08/20/2009US20090209553 Arylpiperazine derivatives and uses thereof
08/20/2009US20090209511 Benzofuran Derivatives
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 694